🔍 Intelligence Synthesis JP/EN
Ethics · Regulation · Technology — Pharma Practice Notes

AI and Cancer Research ── 2026-09-30

Backlit microscope slides: a few aligned and brightly lit stand out among tilted, dim ones, representing validated versus early-stage AI cancer findings.
What this means, as an image (AI-generated, GPT Image): Readers can judge how close each cancer-AI tool is to real clinical use, not just its reported accuracy.Download image (PNG, 2000×800)
How new cancer-and-AI papers are chosen from 26 journals with impact factor 10 or more. Input: papers gathered from those journals' RSS feeds. Editorials, corrections, and items without cancer or AI terms are removed by machine. Jev then judges four points: original research 0.6 or higher, AI centrality 0.6 or higher, one of six themes, treatment or trials 0.5 or higher. Selected papers get summaries from the abstract only, with no efficacy or safety claims. For adenoid cystic carcinoma, the AI requirement is waived since almost no AI papers exist, and an empty issue says so. Output: a digest of 22 papers across six themes, all inside a scope of 26 journals with IF 10 or more.
Image abstract — the whole article on one page (click to enlarge)
22 papers in this issue. Lead: SpaCEy links spatial tissue patterns to clinical outcomes using explainable graph neural networks.

New papers on cancer and AI from 26 medical, oncology and general journals with an impact factor of 10 or more, collected from the journals' own websites and selected by Jev (an AI that makes language judgements): is it original research, is AI central, which of 13 themes, and does it concern treatment or trials. Each entry shows the full original abstract.

Read by cancer type: Cancer biology(12) · Breast(3) · Lung(3) · Pancreatic(2) · Prostate(2) · ACC(0) · Brain(0) · Ovarian(0) · Endometrial(0) · Gastric(0) · Liver(0) · Kidney(0) · Bladder(0)

Cancer molecular biology and AI

See all 12 Cancer biology papers →

Breast cancer: treatment, trials and AI

See all 3 Breast papers →

Lung cancer: treatment, trials and AI

See all 3 Lung papers →

Pancreatic cancer: treatment, trials and AI

See all 2 Pancreatic papers →

Prostate cancer: treatment, trials and AI

See all 2 Prostate papers →

Adenoid cystic carcinoma: treatment, trials and AI

No new qualifying paper in the covered journals for this issue.

Brain tumours: treatment, trials and AI

No new qualifying paper in the covered journals for this issue.

Ovarian cancer: treatment, trials and AI

No new qualifying paper in the covered journals for this issue.

Endometrial cancer: treatment, trials and AI

No new qualifying paper in the covered journals for this issue.

Gastric cancer: treatment, trials and AI

No new qualifying paper in the covered journals for this issue.

Liver cancer: treatment, trials and AI

No new qualifying paper in the covered journals for this issue.

Kidney cancer: treatment, trials and AI

No new qualifying paper in the covered journals for this issue.

Bladder cancer: treatment, trials and AI

No new qualifying paper in the covered journals for this issue.

How papers are chosen: (1) collected from each journal's RSS; (2) editorials, corrections and items without cancer/AI terms are removed; (3) Jev judges four points (original research ≥ 0.6, AI ≥ 0.6, one of 13 themes, treatment/trials ≥ 0.5 for the disease themes). Adenoid cystic carcinoma is a rare cancer with almost no AI papers, so AI is not required for that theme. Papers Jev cannot judge are not listed.